Drug Manufacturing

Search documents
Pres. Trump announces deal with AstraZeneca to lower U.S. drug prices
CNBC Television· 2025-10-10 22:17
Melissa Astroenetica is now the second drug maker to sign on to President Trump's most favored nation drug price program. According to our colleagues at MSNBC reported it earlier. It comes after breaking ground on a $4.5% billion plant in Virginia yesterday where Dr.. Oz was present. CMS administrator Dr. . Oz very much at the center of a lot of these negotiations.And it also comes 10 days after the Fizer agreement to provide drugs. uh at lower prices for Medicaid as well as making a $70 billion investment ...
3 Large Drug Stocks to Watch as Industry Recovers After PFE-Trump Deal
ZACKS· 2025-10-08 13:46
Key Takeaways Pfizer's deal with Trump cuts drug prices, boosts U.S. investment and lifts pharma sector sentiment.Investor optimism grows as major drugmakers eye similar tariff-free pricing agreements with Trump.J&J, Bayer and Novartis show strong growth momentum, making them attractive pharma investment picks.Late last month, Pfizer (PFE) announced a landmark deal with the Trump administration to cut drug prices and expand U.S. innovation and manufacturing.Under the deal, Pfizer agreed to slash prices of s ...
Tariff Tango & Truth Social Twists: The Market’s Wild Ride with Trump
Stock Market News· 2025-10-04 18:01
Ah, the stock market. A bastion of logic, predictability, and calm, right? Not when Donald J. Trump is in the news cycle. As of early October 2025, Wall Street continues its baffling dance to the rhythm of presidential pronouncements, tariff threats, and the occasional, shall we say, unconventional policy proposal. While major indices like the Dow Jones Industrial Average and S&P 500 are busy setting new all-time highs, the underlying currents are a chaotic mix of AI euphoria, trade war jitters, and a gover ...
X @Bloomberg
Bloomberg· 2025-10-01 10:59
“We’re very confident and committed in betting big on the US”Outgoing GSK CEO Emma Walmsley says Pfizer’s drug-pricing agreement with President Trump is a "step forward"BBGWomenMoneyPower https://t.co/D71n0UVSBN https://t.co/LCLyTIsXKC ...
X @The Economist
The Economist· 2025-09-29 23:40
Making drugs in America will not be conducive to keeping costs low, and production will also rely on imports of active ingredients, which could be vulnerable to further protectionism https://t.co/D3k7BFcpVP ...
Pharma's drug pricing deadline: Here's what to know
CNBC Television· 2025-09-29 11:59
Pharma companies are expected to submit plans to the Trump administration today for voluntarily lowering drug prices. Angelica Peebles joins us right now with more on the deadline that's approaching and what's happening behind the scenes. Angelica, what are you hearing.Yeah, Becky. Well, so far we haven't heard companies making many concrete promises. Most are telling us that they're in talks with the administration and that they don't have anything to share yet.We've heard a number of CEOs like Lily's Dave ...
Many pharma companies already made U.S. investment promises, says Citi's Geoff Meacham
CNBC Television· 2025-09-26 20:50
President Trump announcing last night as well that he will impose a 100% tariff on pharmaceutical products entering the US starting October 1st unless they are building manufacturing plants here stateside. EU and Japan will be exempt from the 100% uh with the US honoring the 15% cap that was put into place under the current trade deals. The sector taking the news in stride today.See a lot of green right there on the screen with the big pharma names. Our next guest says the move could be a relief for investo ...
SPX Hovers Near Key Support, Pharmaceutical & Truck Tariffs Add Pressure
Youtube· 2025-09-26 13:01
Market Overview - The S&P 500 is attempting to hold the 6,600 level, which is significant as it is close to the 20-day moving average, a key support area since the tariff announcements [2][4] - Recent market activity indicates a rotation towards more defensive positioning, with profit-taking observed [4] Tariff Implications - The U.S. government is set to implement 100% tariffs on all branded prescription drugs, excluding generics, which may benefit companies like Eli Lilly and JNJ that are expanding manufacturing in the U.S. [6][8] - The pharmaceutical industry imported approximately $213 billion worth of prescription drugs in 2024, indicating a substantial impact from the new tariffs [9][10] - If generics are included in future tariff considerations, it could negatively affect both consumers and manufacturers, as generics are a significant volume driver for profitability [9] Industry-Specific Impacts - The furniture sector is facing 50% tariffs on kitchen cabinets and bathroom vanities, and 30% tariffs on upholstered furniture, primarily affecting imports from China and Vietnam [12][13] - Heavy-duty trucks are subject to 45% tariffs, which may not have an immediate impact due to a decline in demand over the past few years [14][15] TikTok Deal Developments - The Trump administration has approved a deal involving TikTok, with the entity valued at around $14 billion, significantly lower than market expectations [17][18] - The deal includes Oracle and aims to secure U.S. data and algorithms, which is seen as a significant achievement for the administration [16][18]
X @Bloomberg
Bloomberg· 2025-09-26 07:18
Trump’s plan to impose a 100% tariff on branded and patented drugs could sharply raise costs for pharmaceutical companies without US manufacturing capacity https://t.co/hl6fZpwnog ...
X @The Wall Street Journal
The Wall Street Journal· 2025-09-17 11:02
GSK and Eli Lilly are the latest multinational drugmakers to unveil plans to build more U.S. manufacturing plants and other operations, moves aimed partly at mitigating the threat of tariffs https://t.co/QnHi8SQKG1? ...